Systemic Therapy for Soft Tissue Sarcoma: Proposals for the Optimal Use of Pazopanib, Trabectedin, and Eribulin

por Kawai, Akira, Yonemori, Kan, Takahashi, Shunji, Araki, Nobuhito, Ueda, Takafumi
Publicado en Adv Ther (2017)

Phase I and pharmacokinetic study of trabectedin, a DNA minor groove binder, administered as a 24-h continuous infusion in Japanese patients with soft tissue sarcoma

por Ueda, Takafumi, Kakunaga, Shigeki, Ando, Masashi, Yonemori, Kan, Sugiura, Hideshi, Yamada, Kenji, Kawai, Akira
Publicado 2014

Neoadjuvant crizotinib in ALK-rearranged inflammatory myofibroblastic tumor of the urinary bladder: A case report

por Nagumo, Yoshiyuki, Maejima, Aiko, Toyoshima, Yuta, Komiyama, Motokiyo, Yonemori, Kan, Yoshida, Akihiko, Fujimoto, Hiroyuki
Publicado en Int J Surg Case Rep (2018)

Immunohistochemical Profile for Unknown Primary Adenocarcinoma

por Hashimoto, Kenji, Sasajima, Yuko, Ando, Masashi, Yonemori, Kan, Hirakawa, Akihiro, Furuta, Koh, Tsuda, Hitoshi, Fujiwara, Yasuhiro
Publicado 2012

Content Analysis of Oncology-Related Pharmaceutical Advertising in a Peer-Reviewed Medical Journal

por Yonemori, Kan, Hirakawa, Akihiro, Ando, Masashi, Hirata, Taizo, Yunokawa, Mayu, Shimizu, Chikako, Tamura, Kenji, Fujiwara, Yasuhiro
Publicado 2012

Use of Cox's Cure Model to Establish Clinical Determinants of Long-Term Disease-Free Survival in Neoadjuvant-Chemotherapy-Treated Breast Cancer Patients without Pathologic Complete...

por Asano, Junichi, Hirakawa, Akihiro, Hamada, Chikuma, Yonemori, Kan, Hirata, Taizo, Shimizu, Chikako, Tamura, Kenji, Fujiwara, Yasuhiro
Publicado 2013

Visualization of the distribution of nanoparticle-formulated AZD2811 in mouse tumor model using matrix-assisted laser desorption ionization mass spectrometry imaging

por Ryu, Shoraku, Ohuchi, Mayu, Yagishita, Shigehiro, Shimoi, Tatsunori, Yonemori, Kan, Tamura, Kenji, Fujiwara, Yasuhiro, Hamada, Akinobu
Publicado en Sci Rep (2020)

Drug induced interstitial lung disease in oncology phase I trials

por Yonemori, Kan, Hirakawa, Akihiro, Kawachi, Asuka, Kinoshita, Fumie, Okuma, Hitomi, Nishikawa, Tadaaki, Tamura, Kenji, Fujiwara, Yasuhiro, Takebe, Naoko
Publicado en Cancer Sci (2016)

Efficacy of capecitabine in patients with locally advanced or metastatic breast cancer with or without prior treatment with fluoropyrimidine: a retrospective study

por Iizumi, Sakura, Shimomura, Akihiko, Shimoi, Tatsunori, Sudo, Kazuki, Noguchi, Emi, Yonemori, Kan, Shimizu, Chikako, Fujiwara, Yasuhiro, Tamura, Kenji
Publicado en Cancer Chemother Pharmacol (2018)

Anticancer Agent‐Induced Life‐Threatening Skin Toxicities: A Database Study of Spontaneous Reporting Data

por Tanaka, Ryota, Yonemori, Kan, Hirakawa, Akihiro, Kinoshita, Fumie, Kobayashi, Yumiko, Yamazaki, Naoya, Fujimoto, Manabu, Tamura, Kenji, Fujiwara, Yasuhiro
Publicado en Oncologist (2018)

Breast Cancer Brain Metastasis—Overview of Disease State, Treatment Options and Future Perspectives

por Watase, Chikashi, Shiino, Sho, Shimoi, Tatsunori, Noguchi, Emi, Kaneda, Tomoya, Yamamoto, Yusuke, Yonemori, Kan, Takayama, Shin, Suto, Akihiko
Publicado en Cancers (Basel) (2021)

Efficacy of second-line treatment and prognostic factors in patients with advanced malignant peritoneal mesothelioma: a retrospective study

por Kitadai, Rui, Shimoi, Tatsunori, Sudo, Kazuki, Noguchi, Emi, Nagata, Yusuke, Sawada, Ryoichi, Takashima, Atsuo, Boku, Narikazu, Yonemori, Kan
Publicado en BMC Cancer (2021)

Primary Yolk Sac Tumor of the Omentum: A Case Report and Literature Review

por Harano, Kenichi, Ando, Masashi, Sasajima, Yuko, Yunokawa, Mayu, Yonemori, Kan, Shimizu, Chikako, Tamura, Kenji, Katsumata, Noriyuki, Tsuda, Hitoshi, Fujiwara, Yasuhiro
Publicado 2012

Pathological features of triple‐negative breast cancers that showed progressive disease during neoadjuvant chemotherapy

por Tanabe, Yuko, Tsuda, Hitoshi, Yoshida, Masayuki, Yunokawa, Mayu, Yonemori, Kan, Shimizu, Chikako, Yamamoto, Seiichiro, Kinoshita, Takayuki, Fujiwara, Yasuhiro, Tamura, Kenji
Publicado en Cancer Sci (2017)

Response to Dabrafenib and Trametinib of a Patient with Metaplastic Breast Carcinoma Harboring a BRAF V600E Mutation

por Seo, Takuji, Noguchi, Emi, Yoshida, Masayuki, Mori, Taisuke, Tanioka, Maki, Sudo, Kazuki, Shimomura, Akihiko, Yonemori, Kan, Fujiwara, Yasuhiro, Tamura, Kenji
Publicado en Case Rep Oncol Med (2020)

Phase 1 study of telisotuzumab vedotin in Japanese patients with advanced solid tumors

por Fujiwara, Yutaka, Kenmotsu, Hirotsugu, Yamamoto, Noboru, Shimizu, Toshio, Yonemori, Kan, Ocampo, Christopher, Parikh, Apurvasena, Okubo, Sumiko, Fukasawa, Kazuteru, Murakami, Haruyasu
Publicado en Cancer Med (2021)

Phase 1 pharmacokinetic study of the oral pan-AKT inhibitor MK-2206 in Japanese patients with advanced solid tumors

por Doi, Toshihiko, Tamura, Kenji, Tanabe, Yuko, Yonemori, Kan, Yoshino, Takayuki, Fuse, Nozomu, Kodaira, Makoto, Bando, Hideaki, Noguchi, Kazuo, Shimamoto, Takashi, Ohtsu, Atsushi
Publicado en Cancer Chemother Pharmacol (2015)

The Incidence of Nonmalignant Diseases among Patients with Suspected Carcinoma of Unknown Primary Site

por Sato, Jun, Shimoi, Tatsunori, Shimomura, Akihiko, Noguchi, Emi, Kodaira, Makoto, Yunokawa, Mayu, Yonemori, Kan, Shimizu, Chikako, Fujiwara, Yasuhiro, Yoshida, Masayuki, Tamura, Kenji
Publicado en Intern Med (2019)

First‐in‐human study of the cancer peptide vaccine TAS0313 in patients with advanced solid tumors

por Kondo, Shunsuke, Shimizu, Toshio, Koyama, Takafumi, Sato, Jun, Iwasa, Satoru, Yonemori, Kan, Fujiwara, Yutaka, Shimomura, Akihiko, Kitano, Shigehisa, Tamura, Kenji, Yamamoto, Noboru
Publicado en Cancer Sci (2021)

Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugs

por Hata, Tomomi, Nakamura, Kenichi, Yonemori, Kan, Noguchi, Emi, Watanabe, Makiko, Sohn, Joohyuk, Lu, Yen‐Shen, Yap, Yoon‐Sim, Tamura, Kenji, Fujiwara, Yasuhiro
Publicado en Clin Transl Sci (2021)